CN1680321A - Preparation of miglitol - Google Patents

Preparation of miglitol Download PDF

Info

Publication number
CN1680321A
CN1680321A CN 200510037675 CN200510037675A CN1680321A CN 1680321 A CN1680321 A CN 1680321A CN 200510037675 CN200510037675 CN 200510037675 CN 200510037675 A CN200510037675 A CN 200510037675A CN 1680321 A CN1680321 A CN 1680321A
Authority
CN
China
Prior art keywords
formula
reaction
ester
preparation
obtains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510037675
Other languages
Chinese (zh)
Other versions
CN1324010C (en
Inventor
苏国强
柴玉柱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Provincial Institute of Materia Medica Co Ltd
Original Assignee
Jiangsu Provincial Institute of Materia Medica Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Provincial Institute of Materia Medica Co Ltd filed Critical Jiangsu Provincial Institute of Materia Medica Co Ltd
Priority to CNB2005100376754A priority Critical patent/CN1324010C/en
Publication of CN1680321A publication Critical patent/CN1680321A/en
Application granted granted Critical
Publication of CN1324010C publication Critical patent/CN1324010C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Production of miglina is carried out by providing chiral center by L-phenylalanine. It achieves high efficiency and good optical purity, and to avoid chemical resolution and asymmetric hydrogenation.

Description

A kind of preparation method of mitiglinide
Technical field
The present invention relates to a kind of preparation method of mitiglinide.
Background technology
Mitiglinide is an antidiabetic drug, and its mechanism of action is similar to sulfonylurea hypoglycemic agent, mainly acts on the ATP susceptibility K of beta cell +Passage promotes insulin secretion.The mitiglinide preparation method is many, mainly contains chemical resolution method and asymmetric hydrogenation method.
Chemical resolution method has the R-isomer of half to utilize, and yield is low, cost height (method 1).The expensive rhodium complex of asymmetric hydrogenation method needs (rhodium/(2S, 4S)-N-butoxy carbonyl-4-diphenylphosphino-2-diphenylphosphino crassitude), make production cost improve greatly, be unfavorable for suitability for industrialized production (method 2).
Method 1: chemical resolution method
Figure A20051003767500031
Method 2: asymmetric hydrogenation method
Figure A20051003767500032
Summary of the invention
The object of the invention provides a kind of preparation method of mitiglinide, and its chiral carbon atom provides chirality by the L-phenylalanine.
Purpose of the present invention can reach by following measure:
X is chlorine, bromine halogen atom among its Chinese style II, and Z and Z` are cyano group, ester group or amide group in the formula III.
The present invention has following advantage compared to existing technology:
Chiral carbon atom in the mitiglinide is provided by the L-phenylalanine, avoided chemical resolution method to have the R-isomer of half to utilize, and the expensive rhodium complex of asymmetric hydrogenation method needs (rhodium/(2S, 4S)-N-butoxy carbonyl-4-diphenylphosphino-2-diphenylphosphino crassitude).The starting material that the inventive method adopted are cheap and easy to get, the processing condition gentleness, and the optical purity of products height is convenient to suitability for industrialized production.
Embodiment
Embodiment 1
(S)-2-chlorobenzene propionic acid
In the 5000ml reaction flask, add 6N hydrochloric acid 3000ml, cryosel is bathed cooling and is added L-phenylalanine-3,4-quinone 30g (2mol) down, stir, drip 36% sodium nitrite in aqueous solution 850g below 0 ℃, drip off room temperature reaction and spend the night, tell little yellow organic layer, water layer merges and adds an amount of anhydrous sodium sulfate drying with ethyl acetate extraction.Remove ethyl acetate under reduced pressure, get the about 360g of little yellow raffinate,
Figure A20051003767500042
(methyl alcohol), yield 97.5% (directly the next step).
(S)-2-chlorobenzene ethyl propionate
In the 3000ml reaction flask, add (S)-2-chloro-3-phenylpropionic acid 351g (1.90mol), methylene dichloride 770ml, 98% sulfuric acid 7.8ml, the ice bath cooling drips dehydrated alcohol 1000ml down, drip off stirring at room reaction 48hr, the washing of 2N saleratus water liquid, anhydrous sodium sulfate drying, decompression is steamed to slip and is collected 118~122 ℃/5mmHg cut 282.5g, yield 70.0%
Figure A20051003767500043
(dehydrated alcohol).
(S)-the 2-bromo-hydrocinnamic acid
In the 3000ml reaction flask, add 6N hydrochloric acid 1500ml, cryosel is bathed cooling and is added L-phenylalanine 165g (1mol) down, stir, drip 20% sodium nitrite in aqueous solution 500g below 0 ℃, drip off room temperature reaction and spend the night, tell little yellow organic layer, water layer merges and adds an amount of anhydrous sodium sulfate drying with ethyl acetate extraction.Remove ethyl acetate under reduced pressure, get the about 200g of little yellow raffinate,
Figure A20051003767500051
(methyl alcohol).
(S)-2-bromo-hydrocinnamic acid ethyl ester
Method is (S)-2-chlorobenzene ethyl propionate together, yield 65%,
Figure A20051003767500052
(methylene dichloride).
Embodiment 2
(S)-2-benzyl Succinic Acid
In the 1000ml reaction flask, add anhydrous N, dinethylformamide 625ml, activity methene compound (0.4mol), cryosel is bathed to be cooled to and is added 50% sodium hydrogen 48g (1mol) below 0 ℃, stir down and drip (S)-2-halo-3-phenylpropionic acid ethyl ester (0.4mol), keep cryosel and bathe stirring reaction 30min, again in stirring at room.In the about 500g trash ice of reaction solution impouring, ethyl acetate extraction, anhydrous sodium sulfate drying, remove solvent under reduced pressure, get the yellowish brown raffinate, add acetate 400ml, 37% hydrochloric acid 400ml, heating reflux reaction, be evaporated to small volume, crystallization spends the night in the impouring trash ice, gets white solid (the results are shown in Table 1).
Formula II Formula III Reaction times Yield Specific optical rotation (ethyl acetate)
????X=Cl ?Z=CN;Z`=COOEt ????6h ??55% ????-27.8°
????X=Br ?Z=CN;Z`=COOEt ????4h ??68% ????-28.4°
????X=Cl ?Z=Z`=CN ????6h ??75% ????-28.5°
????X=Br ?Z=Z`=CN ????6h ??83% ????-27.9°
????X=Cl ?Z=Z`=COOEt ????8h ??43% ????-23.6°
Embodiment 3
(S)-2-benzyl Succinic anhydried
In the 1000ml reaction flask, add (S)-2-benzyl Succinic Acid 62.5g (0.3mol), diacetyl oxide 220ml (2.33mol), in 75-80 ℃ of reaction 1hr.Cooling back adds the about 415ml of isopropyl ether, puts that crystallization spends the night in the refrigerator, gets white solid 39.7g, and mp122-125 ℃, yield 69.6%,
Figure A20051003767500054
(ethyl acetate).
Embodiment 4
Mitiglinide
In the 1000ml reaction flask, add (S)-2-benzyl Succinic anhydried 38.0g (0.20mol), methylene dichloride 815ml, cryosel is bathed cooling, drips (cis)-hexahydroisoindoline, and room temperature reaction 2hr, concentrating under reduced pressure get light yellow dope 89g, (C=1.0, methyl alcohol).
The mitiglinide calcium salt
In the 1000ml reaction flask, mitiglinide 89g, water 500ml, strong aqua 30ml stir gradually moltenly entirely, drip the Calcium Chloride Powder Anhydrous aqueous solution, and gradually the adularescent solid is separated out, and again in stirred overnight at room temperature, filters after dripping off, and the aqueous ethanolic solution recrystallization gets calcium salt 65g, (C=1.0, methyl alcohol).

Claims (1)

1. the preparation method of (S)-2-benzyl Succinic Acid (formula I),
It is characterized in that L-phenylalanine or its ester are made (S)-2-halogeno-benzene propionic acid or ester (formula II) through the diazotization halo:
Formula II and active methylene (formula III) reaction obtains formula IV:
X is chlorine, bromine halogen atom among its Chinese style II, and Z and Z` are cyano group, ester group or amide group in the formula III;
Formula IV obtains (S)-2-benzyl Succinic Acid (formula V) through the hydrolysis decarboxylation reaction:
Figure A2005100376750002C4
Formula V dehydration generates acid anhydrides and obtains formula I with the hexahydroisoindoline reaction again.
CNB2005100376754A 2005-01-12 2005-01-12 Preparation of miglitol Expired - Fee Related CN1324010C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100376754A CN1324010C (en) 2005-01-12 2005-01-12 Preparation of miglitol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100376754A CN1324010C (en) 2005-01-12 2005-01-12 Preparation of miglitol

Publications (2)

Publication Number Publication Date
CN1680321A true CN1680321A (en) 2005-10-12
CN1324010C CN1324010C (en) 2007-07-04

Family

ID=35067162

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100376754A Expired - Fee Related CN1324010C (en) 2005-01-12 2005-01-12 Preparation of miglitol

Country Status (1)

Country Link
CN (1) CN1324010C (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100441570C (en) * 2006-05-24 2008-12-10 严洁 Preparation of mitiglinide calcium and its quality control method
CN102382033A (en) * 2010-08-31 2012-03-21 凯瑞斯德生化(苏州)有限公司 Preparation methods for optical activity mitiglinide ester and mitiglinide salt
CN104693109A (en) * 2013-12-05 2015-06-10 陕西师范大学 A preparing method of a miglitol intermediate
CN102911107B (en) * 2012-09-28 2015-11-25 迪沙药业集团有限公司 The preparation method of S 21403
CN107879927A (en) * 2017-11-17 2018-04-06 中国药科大学 A kind of method for preparing α chlorinated carboxylic acids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU654331B2 (en) * 1991-03-30 1994-11-03 Kissei Pharmaceutical Co. Ltd. Succinic acid compounds
FR2765578B1 (en) * 1997-07-03 1999-09-10 Adir PROCESS FOR THE PREPARATION OF A SUBSTITUTED PERHYDROISOINDOLE
FR2805535B1 (en) * 2000-02-25 2002-04-12 Adir NEW PROCESS FOR THE PREPARATION OF ISOINDOLINE
WO2003062186A1 (en) * 2002-01-22 2003-07-31 Kissei Pharmaceutical Co., Ltd. Metal salts of (3s)-3-methoxycarbonyl-4-phenylbutyric acid and usage thereof
CN100506794C (en) * 2003-11-13 2009-07-01 中国科学院上海药物研究所 New method for preparing medicine mitiglinide for treating diabetes

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100441570C (en) * 2006-05-24 2008-12-10 严洁 Preparation of mitiglinide calcium and its quality control method
CN102382033A (en) * 2010-08-31 2012-03-21 凯瑞斯德生化(苏州)有限公司 Preparation methods for optical activity mitiglinide ester and mitiglinide salt
CN102382033B (en) * 2010-08-31 2013-04-03 凯瑞斯德生化(苏州)有限公司 Preparation methods for optical activity mitiglinide ester and mitiglinide salt
CN102911107B (en) * 2012-09-28 2015-11-25 迪沙药业集团有限公司 The preparation method of S 21403
CN104693109A (en) * 2013-12-05 2015-06-10 陕西师范大学 A preparing method of a miglitol intermediate
CN107879927A (en) * 2017-11-17 2018-04-06 中国药科大学 A kind of method for preparing α chlorinated carboxylic acids

Also Published As

Publication number Publication date
CN1324010C (en) 2007-07-04

Similar Documents

Publication Publication Date Title
CN1324010C (en) Preparation of miglitol
CN106916060B (en) Preparation method of high-purity p-hydroxyacetophenone
JPH0512355B2 (en)
CN1861554A (en) Production tech, of 3,4,5 trifluorophenol
CN113788756B (en) Method for synthesizing optically pure allyl alcohol compound through diacid catalysis in green mode
CN111875495A (en) Synthetic method of octadecadienecarboxylic acid mono-tert-butyl ester
CN102827015B (en) Preparation method of 5-aminolevulinic acid (ALA) hydrochloride
CN1269782C (en) Method for synthesizing pterostilbene
CN104402690B (en) The preparation method of method Buddhist nun's aldehyde and accompany the preparation method of auspicious tretinoin
CN101875603B (en) Preparation method for synthesizing intermediate mutilin from pleuromutilin antibiotics
CN1803778A (en) Method for preparing 2,4,6-trichloro pyrimidine
CN112047804A (en) Preparation method of 3, 5-dichloro-4-fluorobromobenzene compound
CN101914023B (en) Preparation method of optically pure 4-aryl-2-hydroxy-butyric ester
CN1546464A (en) Method for synthesizing carbanilate by the reaction of aniline, urea and alcohol
CN101157608A (en) Method for preparing 4-pentenoic acid
CN101585762B (en) Method for synthesizing 2-(4-cyclopropoxycarbonylphenyl)-2-methylpropanoic acid
CN101041618A (en) New production technique of cyclohexyl allyl propionate
CN1247504C (en) Process for preparing beta-halogen-alpha-phenyl ethyl alcohol compounds
CN111187161B (en) Preparation method of dihydrocapsaicin and dihydrocapsaicin ester
CN1762941A (en) Leaf alcohol synthesis method
CN116640048B (en) Preparation method of 4,4' -biphenol
CN1271024C (en) Method for synthesizing 3,5-dibasic-1-adamantine alcohol
CN1872831A (en) Method for preparing key intermediate of medication for anti AIDS
CN102503830B (en) Method for catalytic synthesis of benzoic ether by using Ti3AlC2 and Ti2AIC ceramic materials
CN101962320B (en) Method for preparing intermediate 1,2-dicarboxylicacid of antidiabetic medicine gliclazide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: JIANGSU PROVINCIAL INSTITUTE OF MATERIA MEDICA CO.

Free format text: FORMER OWNER: JIANGSU PROVINCIAL INSTITUTE OF MATERIA MEDICA

Effective date: 20101224

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20101224

Address after: 210009, Ma 26 street, Xuanwu Gate, Jiangsu, Nanjing

Patentee after: Jiangsu Provincial Institute of Materia Medica Co., Ltd.

Address before: 210009, Ma 26 street, Xuanwu Gate, Jiangsu, Nanjing

Patentee before: Jiangsu Provincial Institute of Materia Medica

EE01 Entry into force of recordation of patent licensing contract

Assignee: Changzhou Tianhua Pharmaceutical Co., Ltd.

Assignor: Jiangsu Provincial Institute of Materia Medica Co., Ltd.

Contract record no.: 2011320000025

Denomination of invention: Preparation of miglitol

Granted publication date: 20070704

License type: Exclusive License

Open date: 20051012

Record date: 20110127

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070704

Termination date: 20120112